Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp [Phase 3]

View source ↗

Summary

This document notes a Phase 3 clinical trial evaluating a reformulated Levulan Kerastick plus photodynamic therapy for actinic keratosis on the face and scalp, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levulan Kerastick Plus PDT (5-aminolevulinic acid–based photodynamic therapy)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Actinic Keratosis | Phase 3 | Status: RECRUITING